Cadara

Cadara announced a leadership change on August 25, 2026. Cadara, formerly National Care Systems, appointed former SmartLinx CEO Marina Aslanyan to lead the post-acute care technology company’s strategy, product innovation, customer success, and commercial growth.

What changed

Marina Aslanyan was named Chief Executive Officer.

• Leader: Marina Aslanyan
• Role: Chief Executive Officer
• Effective: Not specified in the announcement
• Announcement date: August 25, 2026

Leadership background

Aslanyan brings more than 25 years of executive leadership experience in enterprise software and healthcare technology, the company said. Most recently she served as Chief Executive Officer of SmartLinx and previously was president of Altitude Strategic Consulting. Earlier executive roles included positions at Sparta Systems, Andersen Consulting, PricewaterhouseCoopers, EDS, and Barr Laboratories.

The mandate

Cadara said Aslanyan will lead its long-term strategy, product innovation, customer success, and commercial growth while advancing its mission of helping post-acute organizations optimize operational and financial outcomes. The company said it is accelerating investments in artificial intelligence, organizational growth, and next-generation technologies to support the evolving needs of post-acute care.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Cadara leadership announcement.